Virtualscopics Inc (VSCP) 4.04 $VSCP BioTelemetry, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Virtualscopics Inc (VSCP) 4.04 $VSCP

BioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc.
GlobeNewswire - Wed May 11, 8:25AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that it has completed its acquisition of VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions. The acquisition comes after the successful completion of the all cash tender offer for all outstanding common and preferred shares of VirtualScopics. The total purchase consideration was approximately $15.0 million, net of cash and debt acquired.
VSCP: 4.04 (+0.01), BEAT: 17.29 (+0.75)

BioTelemetry, Inc. Announces Results of Tender Offer for Shares of VirtualScopics, Inc.
GlobeNewswire - Tue May 10, 7:05AM CDT
BioTelemetry, Inc. (NASDAQ: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that the tender offer of its wholly owned subsidiary, BioTelemetry Research Acquisition Corporation ("Offeror", to purchase all outstanding common and preferred shares of VirtualScopics, Inc. ("VirtualScopics"; (NASDAQ:VSCP) at an offer price of $4.05 per share for VirtualScopics' common stock, $336.30 per share for VirtualScopics' Series A and Series B Convertible Preferred Stock and $920.00 per share for VirtualScopics' Series C-1 Convertible Preferred Stock, expired as scheduled at 5:00 p.m., New York City time, on Monday, May 9, 2016, and was not extended.
VSCP: 4.04 (+0.01), BEAT: 17.29 (+0.75)

BioTelemetry, Inc. Commences Previously Announced Tender Offer to Acquire VirtualScopics, Inc.
GlobeNewswire - Fri Apr 08, 3:05PM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that its wholly owned subsidiary, BioTelemetry Research Acquisition Corporation ("Offeror", is commencing a cash tender offer to purchase all outstanding common and preferred shares of VirtualScopics, Inc. ("VirtualScopics" (NASDAQ:VSCP) at an offer price of $4.05 per share for VirtualScopics' common stock, $336.30 per share for VirtualScopics' Series A and Series B Convertible Preferred Stock and $920.00 per share for VirtualScopics' Series C-1 Convertible Preferred Stock. The tender offer is being made pursuant to an Offer to Purchase, dated April 8, 2016, and in connection with the Agreement and Plan of Merger, dated March 25, 2016, among BioTelemetry, Offeror and VirtualScopics, which BioTelemetry and VirtualScopics previously announced on March 25, 2016.
VSCP: 4.04 (+0.01), BEAT: 17.29 (+0.75)

VirtualScopics, Inc. Cancels Conference Call Due To Recent Announcement Of The Definitive Agreement With BioTelemetry, Inc.
PR Newswire - Tue Mar 29, 7:50AM CDT
VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced it will not hold its conference call, or provide its webcast, previously scheduled for Wednesday, March 30, 2016 at 8:30 a.m. ET.
VSCP: 4.04 (+0.01), BEAT: 17.29 (+0.75)

VIRTUALSCOPICS INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to BioTelemetry, Inc.
BusinessWire - Mon Mar 28, 2:54PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of VirtualScopics Inc. ("VirtualScopics" (NasdaqCM: VSCP) concerning the sale to BioTelemetry, Inc. Under the terms of the agreement, VirtualScopics common shareholders will only receive $4.05 per share, which is virtually no premium over the 52-week high and lower than at least one analyst's estimated value of $7.00 per share. Series A and Series B Convertible Preferred Stock shareholders will receive $336.30 per share and Series C-1 Convertible Preferred Stock holders will receive $920.00 per share. The tender offer is expected to commence on April 11, 2016 and will be open for a minimum of 20 business days.
VSCP: 4.04 (+0.01), BEAT: 17.29 (+0.75)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of VirtualScopics Inc. to BioTelemetry, Inc. is Fair to Shareholders -- VSCP
ACCESSWIRE - Mon Mar 28, 9:14AM CDT
NEW YORK, NY / ACCESSWIRE / March 28, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
VSCP: 4.04 (+0.01), BEAT: 17.29 (+0.75)

BioTelemetry, Inc. Signs Definitive Agreement to Acquire VirtualScopics, Inc.
GlobeNewswire - Fri Mar 25, 10:30AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, announced today that the two companies have entered into a definitive agreement whereby BioTelemetry will acquire VirtualScopics.
VSCP: 4.04 (+0.01), BEAT: 17.29 (+0.75)

VirtualScopics, Inc. Announces Amendment to Exclusive Marketing Agreement with PPD; Provides Additional Opportunities to Develop New Business Relationships
PR Newswire - Fri Jan 22, 8:00AM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that it is amending its alliance agreement with PPD, a contract research organization (CRO), to eliminate the marketing exclusivity portion of the agreement, effective April 11, 2016. The agreement originally signed in 2010, which focused on oncology trials and was later expanded to include other therapeutic areas, restricted VirtualScopics and PPD from co-marketing with each other's competitors. Under the amended agreement, VirtualScopics and PPD will no longer be restricted by exclusive co-marketing. Going forward, they will continue to collaborate on joint imaging projects already underway, as well as those in the current backlog. In addition, they will continue to work together to win new business for their alliance.
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. Promotes Ronald Way to Chief Operating Officer
PR Newswire - Thu Dec 17, 12:02PM CST
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that Ronald Way, 60, has been promoted to chief operating officer (COO). Mr. Way joined VirtualScopics in January 2011 as director of operations and was promoted to vice president of operations in August 2014. Mr. Way will be responsible for leading all functions required to deliver superb clinical trial imaging solutions to the company's customers using regulatory compliant processes. Mr. Way has contributed to the increased customer loyalty retention rate over the past few years.
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. Reports 2015 Third Quarter Revenues Increase 18% From Prior Year Period And Company Achieves Positive Adjusted EBITDA
PR Newswire - Thu Oct 29, 3:01PM CDT
VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today reported financial results for the third quarter and nine months ended September 30, 2015.
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. to Host Third Quarter 2015 Earnings Conference Call and Webcast Live on Thursday, October 29, 2015
ACCESSWIRE - Wed Oct 28, 3:15PM CDT
ROCHESTER, NY / ACCESSWIRE / October 28, 2015 / VirtualScopics, Inc. (NASDAQ: VSCP) will host a conference call and live webcast to discuss the results of the third quarter 2015, to be held Thursday, October 29, 2015 at 4:30 PM Eastern Time.
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. Schedules Third Quarter 2015 Financial Results Press Release, Conference Call And Webcast
PR Newswire - Wed Oct 14, 7:00AM CDT
VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced it will report its third quarter 2015 financial results at the 4:00 p.m. ET market close on Thursday, October 29, 2015. Eric T. Converse, president and chief executive officer, and Jim Groff, chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 4:30 p.m. ET that afternoon. The conference call and webcast information are as follows:
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. Reports 2015 Second Quarter And Six Months Financial Results; Revenues Increase 14% From 2014 Second Quarter And 17% Above The Six Months Reported In 2014
PR Newswire - Tue Aug 11, 3:01PM CDT
VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today reported financial results for the second quarter and six months ended June 30, 2015. Revenues for the second quarter of 2015 rose 14% to $3,019,126 compared to revenues of $2,648,747 for the comparable prior year period. The company reported a net loss for the second quarter of 2015 of $546,992, or $0.20 loss per share, representing a 25% improvement from a net loss of $731,531, or $0.26 loss per share, reported in the second quarter of 2014. Revenues for the first half of 2015 rose 17% to $5,833,568 compared to revenues of $5,001,732 for the comparable prior year period. The company reported a net loss for the first half of 2015 of $1,099,664, or $0.40 loss per share, representing a 20% improvement from a net loss of $1,377,904, or $0.49 loss per share, reported in the first half of 2014.
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. to Host Second Quarter 2015 Earnings Conference Call and Webcast Live on Tuesday, August 11, 2015
ACCESSWIRE - Mon Aug 10, 3:16PM CDT
ROCHESTER, NY / ACCESSWIRE / August 10, 2015 / VirtualScopics, Inc. (NASDAQ: VSCP) will host a conference call and live webcast to discuss the results of the second quarter 2015, to be held Tuesday, August 11, 2015 at 4:30 PM Eastern Time.
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast
PR Newswire - Tue Jul 28, 7:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that it will report its second quarter 2015 financial results at the 4:00 p.m. ET market close on Tuesday, August 11, 2015. Eric T. Converse, president and chief executive officer, and Jim Groff, chief financial officer, will host a conference call and webcast to discuss the company's financial results and provide a business update at 4:30 p.m. ET that afternoon. Conference call, webcast and replay information is as follows:
VSCP: 4.04 (+0.01)

VirtualScopics and IXICO Alliance Receive Awards in Oncology and Neurodegenerative Disease
PR Newswire - Mon Jun 29, 7:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, along with IXICO plc (AIM: IXI), the brain health company, announced today the alliance has been awarded contracts with two top 15 pharmaceutical companies, one in metastatic solid tumors and one in a rare neurodegenerative disease. IXICO's TrialTracker(TM) digital platform will be deployed in both studies to collect and manage imaging data and in the neurodegeneration study, IXICO's Assessa® digital technology will be used to analyze MRI data collected from patients.
VSCP: 4.04 (+0.01)

Lion Biotechnologies Names Molly Henderson Chief Financial Officer
GlobeNewswire - Mon Jun 08, 7:00AM CDT
Lion Biotechnologies, Inc. (Nasdaq:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced the appointment of Molly Henderson, CPA, as chief financial officer, effective immediately.
VSCP: 4.04 (+0.01), LBIO: 8.44 (-0.20)

VirtualScopics, Inc. Reports Voting Results At Annual Meeting Of Shareholders; All Board Seats Renewed
PR Newswire - Fri Jun 05, 10:00AM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that shareholders have voted for and ratified all three proposals contained in the company's 2015 proxy statement. The outcome of this morning's vote at the Annual Meeting of Shareholders is as follows:
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. To Webcast Annual Meeting Of Shareholders On June 2, 2015; Five Members Of Management To Provide Insight On Operational Excellence And Future Outlook
PR Newswire - Tue May 19, 10:39AM CDT
VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today announced it will webcast the 2015 Annual Meeting of Shareholders on Tuesday, June 2, 2015, beginning at 10:00 a.m. The meeting will be held at the Country Club of Rochester, 2935 East Avenue, Rochester, New York, and is open to all VirtualScopics shareholders. Information for this year's Annual Meeting, including the company's Annual Report, Form 10-K and Proxy Statement, can be found on the company's website, www.virtualscopics.com
VSCP: 4.04 (+0.01)

VirtualScopics, Inc. To Present At The 2015 Marcum MicroCap Conference In New York City
PR Newswire - Wed May 13, 4:05PM CDT
VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, announced today that Eric Converse, president and chief executive officer, will be presenting at the Marcum MicroCap Conference, which will be held at the Grand Hyatt Hotel in New York City, on Wednesday, May 27, 2015 at 3:00 p.m. Mr. Converse will also be conducting one-on-one meetings with institutional investors that afternoon and on Thursday, May 28, 2015.
VSCP: 4.04 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 10

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading

Top 5 Most Recently Viewed Articles

Concerns Over E. Coli Outbreak Cause McDonald's Stock Decline

Updated Category News Views 122

Impact of E. Coli Outbreak on McDonald's Stock McDonald’s Corp. (NYSE: MCD) faced a decline in its stock following alarming news from the CDC regarding an E. coli outbreak associated with its well-known Quarter Pounder burgers. The report, which surfaced after the market closed, raised serious concerns among investors, leading to a notable drop in share value. Details...

Continue Reading
Omineca Mining Resumes Gold Recovery Operations at Wingdam

Updated Category News Views 311

Omineca Mining's Operational Resurgence at Wingdam Omineca Mining and Metals Ltd. (TSXV: OMM, OTCQB: OMMSF) is ecstatic to share exciting news about the operational restart of its underground placer gold recovery program at the Wingdam project. This marks a significant step forward in the company’s commitment to maximizing resource potential and a strong revival of...

Continue Reading
Rezolve Ai's Strategic Acquisition to Lead Future Commerce

Updated Category News Views 291

Rezolve Ai's Bold Move in the Commerce Sector Rezolve Ai (NASDAQ: RZLV) has announced a significant step in redefining digital commerce with its strategic acquisition of Crownpeak. This transformative merger is set to enhance Rezolve's capabilities in providing AI-driven solutions across various industries, including retail, fashion, beauty, manufacturing, and financial...

Continue Reading
Innovative Trends Boosting Folding Electric Bicycle Market Growth

Updated Category News Views 124

Significant Growth in the Folding Electric Bicycle Market The global folding electric bicycle market is on an exciting trajectory, set to expand by USD 264.9 million between 2025 and 2029. This growth is fueled by urban traffic congestion and an increasing preference for lightweight and eco-friendly transportation modes among commuters. The market is predicted to grow at...

Continue Reading
Network Brainiacs Expands Footprint into Maryland Market

Updated Category News Views 150

Network Brainiacs Steps into Maryland Territory If you're in the tech services game, expansion stories are the bread and butter of this business. Network Brainiacs, a seasoned veteran in the managed IT and cybersecurity sectors, has taken their first big step into Maryland by acquiring Computer Enhancement Systems (CES), a notable player in the field, as of September 1,...

Continue Reading